Gilead to acquire remaining worldwide rights of breast cancer drug, Trodelvy
All of Everest Medicine's development and commercialization rights for a breast cancer drug called Trodelvy…
All of Everest Medicine's development and commercialization rights for a breast cancer drug called Trodelvy…
Clinical and regulatory setbacks have left the star biotech duo Gilead and Galapagos smarting and…
The recent EU and Japan approvals of the rheumatoid arthritis drug filgotinib contrast with the…
Remdesivir has received a one-year conditional marketing authorization from the European Commission due to the…
Gilead has launched a 10-year collaboration with the Belgo-Dutch biotech Galapagos, paying at least €4.5B…
The diagnostics company Biocartis is collaborating with Kite Pharma to monitor the progress of CAR…
Hookipa Pharma has reached its first milestone in a partnership deal with US-based CAR T…
With the addition of uveitis, Galapagos and Gilead are raising to 10 the number of…
GSK announced Phase III results for dolutegravir, which could reduce triple HIV therapy down to…
Galapagos is starting a new PhaseIIb/III clinical trial for ulcerative colitis that has triggered a €9.4M…
After losing AbbVie as a partner, Galapagos has pressed on with Gilead in the development…
Despite progress in HIV treatments and towards an HIV cure, the infection rate has risen…